"
Professor Bond made a similar discovery previously with a particular class of beta blockers with regards to the treatment of chronic heart failure, for which beta blockers were con- traindicated. He brought that discovery to Dr Mitchell Glass (now Invion’s Chief Medical Officer) at GlaxoSmithKline. That subset of drugs became the best drugs ever available to decreasing mortality in heart failure, according to Professor Bond. The discovery moved a $40 million selling drug in 1998 to a $1.5 billion dollar drug in 2010.
For the second time Professor Bond has sought to commercialise his work on contraindications of beta blockers through Dr Mitchell Glass, this time through Invion.
"
Bioshares
potential partners in the biosphere, page-6
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IVX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $20.29M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.3¢ | 0.3¢ | $9.032K | 3.010M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 4029980 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 10133478 | 15 |
View Market Depth
| Last trade - 16.10pm 11/10/2024 (20 minute delay) ? |
| IVX (ASX) Chart |